Pyrido [2, 3-b] pyrazine and [1, 8] - naphthyridine derivatives as ALK and cMet inhibitors

Details for Australian Patent Application No. 2007248603 (hide)

Owner Cephalon, Inc.

Inventors Pippin, Douglas A.; Zificsak, Craig A.; Underiner, Theodore L.; Dorsey, Bruce D.; Theroff, Jay P.; Milkiewicz, Karen L.; Weinberg, Linda

Agent Watermark

Pub. Number AU-B-2007248603

PCT Pub. Number WO2007/130468

Priority 11/799,066 30.04.07 US; 60/796,465 01.05.06 US

Filing date 1 May 2007

Wipo publication date 15 November 2007

Acceptance publication date 1 November 2012

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375

A61K 31/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/130468 Priority application(s): WO2007/130468

1 November 2012 Application Accepted

  Published as AU-B-2007248603

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007248609-Method of differentiating stem cells into cells of the endoderm and pancreatic lineage

2007248587-Method of treating crops with submicron chlorothalonil